Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ted R Mikuls

Showing results (51-60 of 387) with videos related to

Pageof 39
Sort By:
The Journal of Allergy and Clinical Immunology|January 16, 2016
Autoimmunity of the lung and oral mucosa in a multisystem inflammatory disease: The spark that lights the fire in rheumatoid arthritis?Ted R Mikuls, Jeffrey B Payne, Kevin D Deane, et al.
Current Rheumatology Reports|April 27, 2026
Treat-to-Target Urate-lowering Therapy: Lessons Learned from the STOP Gout StudyTed R Mikuls, Lindsay Helget, Jeff Newcomb, et al.
Current Rheumatology Reports|October 16, 2014
Cardiovascular risk and the use of biologic agents in rheumatoid arthritisDebbie T Lim, Amy C Cannella, Kaleb D Michaud, et al.
Arthritis Care & Research|February 12, 2016
Generalizability of Patients With Rheumatoid Arthritis in Biologic Agent Clinical TrialsPriyanka Vashisht, Harlan Sayles, Amy C Cannella, et al.
BMJ (Clinical Research Ed.)|April 25, 2018
Increased cardiovascular risk in rheumatoid arthritis: mechanisms and implicationsBryant R England, Geoffrey M Thiele, Daniel R Anderson, et al.
Arthritis and Rheumatism|August 29, 2009
Presumptive serum sickness as a complication of rabbit-derived antithymocyte globulin immunosuppressionMarcus H Snow, Amy C Cannella, R Brian Stevens, et al.
Pharmacoepidemiology and Drug Safety|November 14, 2018
"Methotrexate and NSAIDs in rheumatoid arthritis-Confirmation of a known NSAIDs adverse effect rather than a dangerous combination"Orwah Al-Khalili, Ted R Mikuls, James R O'Dell, et al.
Arthritis Research & Therapy|November 21, 2013
Rheumatoid arthritis patients are not at increased risk for 30-day cardiovascular events, infections, or mortality after total joint arthroplastyKaleb Michaud, Edward V Fehringer, Kevin Garvin, et al.
The Journal of Rheumatology|May 4, 2005
Racial disparities in the receipt of osteoporosis related healthcare among community-dwelling older women with arthritis and previous fractureTed R Mikuls, Kenneth G Saag, Varghese George, et al.
Arthritis Care & Research|February 12, 2016
Increasing Public Health Burden of Arthritis and Other Rheumatic Conditions and Comorbidity: Results From a Statewide Health Surveillance System, 2007-2012Guang-Ming Han, Kaleb Michaud, Fang Yu, et al.
Pageof 39

Showing results (51-60 of 387) with videos related to

Sort By:
Pageof 39
The Journal of Allergy and Clinical Immunology|January 16, 2016
Autoimmunity of the lung and oral mucosa in a multisystem inflammatory disease: The spark that lights the fire in rheumatoid arthritis?Ted R Mikuls, Jeffrey B Payne, Kevin D Deane, et al.
Current Rheumatology Reports|April 27, 2026
Treat-to-Target Urate-lowering Therapy: Lessons Learned from the STOP Gout StudyTed R Mikuls, Lindsay Helget, Jeff Newcomb, et al.
Current Rheumatology Reports|October 16, 2014
Cardiovascular risk and the use of biologic agents in rheumatoid arthritisDebbie T Lim, Amy C Cannella, Kaleb D Michaud, et al.
Arthritis Care & Research|February 12, 2016
Generalizability of Patients With Rheumatoid Arthritis in Biologic Agent Clinical TrialsPriyanka Vashisht, Harlan Sayles, Amy C Cannella, et al.
BMJ (Clinical Research Ed.)|April 25, 2018
Increased cardiovascular risk in rheumatoid arthritis: mechanisms and implicationsBryant R England, Geoffrey M Thiele, Daniel R Anderson, et al.
Arthritis and Rheumatism|August 29, 2009
Presumptive serum sickness as a complication of rabbit-derived antithymocyte globulin immunosuppressionMarcus H Snow, Amy C Cannella, R Brian Stevens, et al.
Pharmacoepidemiology and Drug Safety|November 14, 2018
"Methotrexate and NSAIDs in rheumatoid arthritis-Confirmation of a known NSAIDs adverse effect rather than a dangerous combination"Orwah Al-Khalili, Ted R Mikuls, James R O'Dell, et al.
Arthritis Research & Therapy|November 21, 2013
Rheumatoid arthritis patients are not at increased risk for 30-day cardiovascular events, infections, or mortality after total joint arthroplastyKaleb Michaud, Edward V Fehringer, Kevin Garvin, et al.
The Journal of Rheumatology|May 4, 2005
Racial disparities in the receipt of osteoporosis related healthcare among community-dwelling older women with arthritis and previous fractureTed R Mikuls, Kenneth G Saag, Varghese George, et al.
Arthritis Care & Research|February 12, 2016
Increasing Public Health Burden of Arthritis and Other Rheumatic Conditions and Comorbidity: Results From a Statewide Health Surveillance System, 2007-2012Guang-Ming Han, Kaleb Michaud, Fang Yu, et al.
Pageof 39